Salud
FDA Advisory Panel Recommends Compounding for Select Unapproved Peptides
The recommendations signal a shift toward broader access for alternative therapies, potentially allowing compounding pharmacies to supply popular but unproven peptide treatments to patients.
IA · verificado6 de 8 afirmaciones con una sola fuente